KANCHAN BHOWMIK: Open Payments
NPI 1497100390 · JOHNSTOWN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 18 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $620 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $446 |
| E.R. Squibb & Sons, L.L.C. | 2 | $140 |
| Indivior Inc. | 1 | $74 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: ARISTADA, VIVITROL, OPDIVO, LYBALVI, SUBLOCADE, UZEDY, REXULTI, ABILIFY ASIMTUFII.
Industry payments across CO — which companies pay providers there.
